Stanford University
Showing 10,951-11,000 of 12,903 Results
-
James Swartz
James H. Clark Professor in the School of Engineering and Professor of Chemical Engineering and of Bioengineering
Current Research and Scholarly InterestsProgram Overview
The world we enjoy, including the oxygen we breathe, has been beneficially created by biological systems. Consequently, we believe that innovative biotechnologies can also serve to help correct a natural world that non-natural technologies have pushed out of balance. We must work together to provide a sustainable world system capable of equitably improving the lives of over 10 billion people.
Toward that objective, our program focuses on human health as well as planet health. To address particularly difficult challenges, we seek to synergistically combine: 1) the design and evolution of complex protein-based nanoparticles and enzymatic systems with 2) innovative, uniquely capable cell-free production technologies.
To advance human health we focus on: a) achieving the 120 year-old dream of producing “magic bullets”; smart nanoparticles that deliver therapeutics or genetic therapies only to specific cells in our bodies; b) precisely designing and efficiently producing vaccines that mimic viruses to stimulate safe and protective immune responses; and c) providing a rapid point-of-care liquid biopsy that will count and harvest circulating tumor cells.
To address planet health we are pursuing biotechnologies to: a) inexpensively use atmospheric CO2 to produce commodity biochemicals as the basis for a new carbon negative chemical industry, and b) mitigate the intermittency challenges of photovoltaic and wind produced electricity by producing hydrogen either from biomass sugars or directly from sunlight.
More than 25 years ago, Professor Swartz began his pioneering work to develop cell-free biotechnologies. The new ability to precisely focus biological systems toward efficiently addressing new, “non-natural” objectives has proven tremendously useful as we seek to address the crucial and very difficult challenges listed above. Another critical feature of the program is the courage (or naivete) to approach important objectives that require the development and integration of several necessary-but- not-sufficient technology advances. -
Andrew Sweatt
Assistant Professor of Medicine (PACCM)
Current Research and Scholarly InterestsAiming to advance understanding and treatment of pulmonary arterial hypertension (PAH), Dr. Sweatt's research leverages high-throughput molecular profiling, deep clinical phenotypic data, and data science (machine learning and network-based analysis) to identify novel sub-phenotypes and therapeutically-relevant biomarkers in PAH.
-
Susan M. Swetter, MD
Professor of Dermatology
Current Research and Scholarly Interests1) Early detection of melanoma through enhanced screening, novel imaging technologies, and professional/public education to improve melanoma awareness. 2) Therapeutic prevention of melanoma and other skin cancers in high-risk groups. 4) Epidemiologic and sociodemographic melanoma risk factors. 4) Dermatologist liaison to ECOG-ACRIN Melanoma Committee and Co-founder/Co-Director of the national Melanoma Prevention Working Group, an interdisciplinary collaboration dedicated to melanoma control.
-
Alexandra Switzer
Basic Life Research Scientist, Microbiology and Immunology
Current Role at StanfordMicrobiologist, veterinarian and data analyst in the Relman lab studying the indigenous gut microbiota of a wide range of marine and terrestrial mammals. Current research interests include characterizing microbiome assembly in neonatal mammals, host-microbiome co-evolution and patterns of microbiome diversity associated with wildlife population health.
-
Ali Bin Syed
Clinical Associate Professor, Radiology - Pediatric Radiology
BioDr. Syed is a member of the divisions of Pediatric Radiology and Body MRI and serves as the Medical Director of Pediatric MRI at Stanford. Dr. Syed has received subspecialty training in adult body imaging, pediatric body imaging, congenital cardiac imaging, and musculoskeletal imaging. His clinical interests include MR imaging of pediatric and adult hepatobiliary disorders, inflammatory bowel disease, gynecologic pathology, and congenital heart disease. He is also an active researcher and works with engineers and scientists to translate technical innovations in MRI into improved patient care. His recent work focuses on translation of machine learning techniques for rapid, robust MRI in children and adults.
-
Karl G. Sylvester
Professor of Surgery (Pediatric Surgery)
Current Research and Scholarly InterestsScholarly interests include investigation of molecular markers of human disease that provide diagnostic function, serve as targets for possible therapeutic manipulation, or provide insight into mechanisms of human disease. Specific diseases of interest include common conditions of pregnancy, gut microbial ecology and Necrotizing Enterocolitis (NEC).
-
Gregory Arthur Szalkowski
Clinical Assistant Professor, Radiation Oncology - Radiation Physics
Current Research and Scholarly InterestsWorkflow automation, radiotherapy quality assurance, machine learning
-
Daniel Sze, MD, PhD
Professor of Radiology (Interventional Radiology), Emeritus
Current Research and Scholarly InterestsTransarterial administration of chemotherapeutics, radioactive microspheres, and biologics for the treatment of unresectable tumors; management of portal hypertension and complications of cirrhosis (TIPS); treatment of complications of organ transplantation; Venous and pulmonary arterial thrombolysis and reconstruction; Stent and Stent-graft treatment of peripheral vascular diseases, aneurysms, aortic dissections
-
Christopher N. Ta, MD
Professor of Ophthalmology
On Leave from 03/23/2026 To 04/25/2026BioChristopher N. Ta, MD specializes in the diagnosis and medical treatment of cornea diseases. His areas of expertise are in the treatment of ocular infections, inflammation, and ocular surface diseases. He has conducted numerous clinical trials toward the prevention and treatment of ocular infections. Dr. Ta also has extensive clinical experience in the treatment of ocular graft-versus host disease following hematopoietic stem cell transplantation.
-
Meg Tabaka, MD, MPH
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Tabaka is a board-certified family medicine physician with a special focus in LGBTQ+ and underserved medicine. She is also a clinical assistant professor in the Division of Primary Care and Population Health of Stanford Department of Medicine. In this role, she splits her time between the Stanford Los Altos LGBTQ+ Primary Care Clinic and the MayView Community Clinic, a Federally Qualified Health Center in Mountain View, CA.
Dr. Tabaka provides expert, compassionate care personalized to each patient she serves. She is dedicated to meeting the health care needs of all of her patients including all members of the LGBTQ+ community and she welcomes patients of all ages and backgrounds to her practice.
Prior to her medical training, Dr. Tabaka completed her Masters in Public Health at the University of Minnesota. She went to complete medical school at Stanford University and completed residency at the Stanford O’Connor Family Medicine Residency Program in San Jose, CA. -
Geoffrey Craig Tabin, MD
Fairweather Foundation Professor
BioDr. Geoff Tabin is Co-Founder and Chairman of the Himalayan Cataract Project and a Professor of Ophthalmology and Global Medicine at Stanford University. He has published more than 45 peer-reviewed articles, two books and a dozen book chapters related to his work in ophthalmology and the developing world.
Dr. Tabin is the fourth person in the world to reach the tallest peak on each of the seven continents. His passion for mountain climbing directed him to his professional career in eye care. After summiting Mt. Everest, on one of his expeditions, he came across a Dutch team performing cataract surgery on a woman who had been needlessly blind for three years. It was then he understood his life calling.
Tabin graduated from Yale University and then earned an MA in Philosophy at Oxford University on a Marshall Scholarship. From there, he took his interest in moral philosophy and health care delivery to Harvard Medical School where he earned his MD in 1985. After completing an ophthalmology residency at Brown University and a fellowship in corneal surgery in Melbourne, Australia, Dr. Tabin returned to Nepal to work with Dr. Sanduk Ruit.
Tabin and Nepalese eye surgeon Dr. Sanduk Ruit established the Himalayan Cataract Project in 1995 – with a vow to work to eliminate all preventable and treatable blindness from the Himalayan region in their lifetime, a goal, in Tabin’s words, “more audacious than setting out to make the first assent of the East Face of Mount Everest.” Dr. Ruit, whom the Associated Press heralded as the “god of sight” to the world’s poor, and Tabin have proven that hospital quality standards can be applied in impoverished areas devoid of electricity and clean water. Their successful approach to restoring sight and dogged perseverance has made possible what 20 years ago seemed impossible.
The Himalayan Cataract Project has since expanded beyond the Himalayas to encompass Sub-Saharan Africa as well. Dr.Tabin spends a considerable part of the year working abroad throughout the Himalayas and Sub-Saharan Africa. At Stanford his practice focus encompasses surgery and treatment of diseases of the anterior and external eye including cataract and corneal surgery. -
Holly Tabor
Professor of Medicine (Primary Care & Population Health) and, by courtesy, of Pediatrics (Stanford Center of Biomedical Ethics) and of Epidemiology
Current Research and Scholarly InterestsMy research focuses on ethical issues in genetics and genomics, specifically return of results and translation for exome and whole genome sequencing and translation of genomic sequencing into the clinical setting. I also conduct research on ethical issues in clinical care and research for patients and families with autism and other developmental and cognitive disabilities.
-
Alaa Taha
MD Student with Scholarly Concentration in Informatics & Data-Driven Medicine / Surgery, expected graduation Spring 2030
BioAlaa completed his PhD in Biomedical Engineering at Western University and is an MD student at Stanford. Alaa's research integrates machine learning, image analysis, and anatomical coordinate systems for brain mapping and deep brain stimulation. Alaa is passionate about global health equity, open-source medical software, and advancing stereotactic neurosurgery through interpretable and reproducible methods.
-
Daniel Tahan
Graduate, Medicine, Surgery
BioDaniel is a visiting researcher in the Division of Pediatric Surgery at Stanford University. He is in the process of completing his medical degree at Tulane University School of Medicine, where he co-founded a student-run clinic for refugee and MENA communities and participates in the DeBakey Scholars Program.
His ongoing research focus involves the study of congenital lung malformations in children, where he is currently exploring the continuum from prenatal diagnosis to long-term postnatal outcomes. A few of his other academic interests include global surgery, surgical education, and surgical disparities research. -
Niloofar Taheri
Postdoctoral Scholar, Psychiatry
BioDr. Niloofar Taheri is a postdoctoral researcher (MD, Inv) in the Mignot Lab at Stanford University, where she conducts research in sleep medicine and neuroimmunology. Her work has been recognized with Gold Medals at international invention competitions, including the IFIA Members’ Competition for developing a novel diagnostic and therapeutic approach to neurodegenerative disorders, and the 2025 American Innovation Exhibition (AIIE) in San Diego, where she received a Gold Medal and Special Prize for designing a medication to improve the treatment of brain metastases in breast cancer. Most recently, she won a Gold Medal at the 2025 Kaohsiung International Invention & Design Expo (KIDE), for a patent on a novel diagnostic method for the early detection of major depressive disorder (MDD).
She brings experience in clinical practice, co-founding an autoimmune society, and developing wet-lab models. She is also a verified peer reviewer for psychiatry and neuroscience journals.
